Do you want to read an article? Please log in or register.
Investigating the causal effect of potential therapeutic agents for colorectal cancer prevention: a Mendelian randomization analysis
Gastrointestinal Cancer
Related content
Gastrointestinal Cancer
Evaluation of the efficacy of probiotics in the chemoradiotherapy of colorectal cancer: a meta-analysis of Randomized Controlled Trials
BMC Gastroenterol
Yang R, Liu W, Cai S, Feng X, Chen Y, Cheng X, Ma J, Ma W, Tian Z, Yang W
doi: 10.1186/s12876-025-03914-y
Gastrointestinal CancerHelicobacter Pylori
Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies
Gastroenterology
Ford AC, Yuan Y, Park JY, Forman D, Moayyedi P
doi: 10.1053/j.gastro.2024.12.033
ColonoscopyGastrointestinal Cancer
Effect of cecal intubation rate on post colonoscopy colorectal cancer deaths and detection of colorectal cancer precursors
Clin Gastroenterol Hepatol
Zessner-Spitzenberg J, Waldmann E, Rockenbauer LM, Demschik A, Klinger A, Penz D, Trauner M, Ferlitsch M
doi: 10.1016/j.cgh.2025.01.035
Gastrointestinal Cancer
Neoadjuvant chemotherapy for colon cancer: A systematic review and meta-analysis of randomized controlled trials
Eur J Cancer
Noronha MM, Costa Almeida LF, Cappellaro AP, Silva LFLD, Conceição LDD, Menezes JSA, Belotto M, Peixoto RD'
doi: 10.1016/j.ejca.2025.115476
Gastrointestinal Cancer
Effectiveness of Gastric Cancer Endoscopic Screening in Intermediate-Risk Countries-A Systematic Review and Meta-Analysis
United European Gastroenterol J
Mourato MB, Pratas N, Branco Pereira A, Chança R, Fronteira I, Dinis R, Areia M
doi: 10.1002/ueg2.70084
ColonoscopyGastrointestinal Cancer
Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial
Lancet
Castells A, Quintero E, Bujanda L, Castán-Cameo S, Cubiella J, Díaz-Tasende J, Lanas Á, Ono A, Serra-Burriel M, Frías-Arrocha E, Hernández C, Jover R, Andreu M, Carballo F, Morillas JD, Salas D, Almazán R, Alonso-Abreu I, Banales JM, Hernández V, Portillo I, Vanaclocha-Espí M, de la Vega M, COLONPREV study investigators
doi: 10.1016/S0140-6736(25)00145-X
Gastrointestinal Cancer
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis
Eur J Cancer
Bregni G, Leurquin B, Giasafaki P, Takemura N, Kokudo N, Hasegawa K, Matsuyama Y, Nishioka Y, Aparicio T, Guimbaud R, Malicot KL, Tu D, O'Callaghan C, Lutz MP, Fontana E, Moehler M, Mauer ME, Sclafani F
doi: 10.1016/j.ejca.2025.116092
Gastrointestinal Cancer
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)
Eur J Cancer
Weiss L, Stintzing S, Modest DP, Stahler A, von Weikersthal LF, Reinacher-Schick A, Decker T, Probst V, Heinrich K, Schwaner I, Kaiser F, Pihusch R, Fuchs M, Held S, Alig A, Gruenberger B, Prager GW, Tougeron D, Taieb J, Heinemann V
doi: 10.1016/j.ejca.2025.116105
COMMENTED
ColonoscopyGastrointestinal Cancer
Colorectal cancer screening based on predicted risk: a randomized controlled trial
★ 2
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Plys E, Bulliard JL, Chaouch A, Durand MA, van Duuren LA, Braendle K, Auer R, Froehlich F, Vogelaar IL, Corley DA, Selby K
doi: 10.14309/ajg.0000000000003311